BDNF and relapsing-remitting multiple sclerosis: It cannot be excluded that the Met-allele also influences the ability of BDNF to limit the excitotoxic effects of neuroinflammation when secreted from immune cells in RRMS patients in response to relapses and during remitting phases [31].